11-108250683-CTTTTTTT-CTTTTTT

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong

The NM_000051.4(ATM):​c.1236-3delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). The gene ATM is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 0)
Exomes 𝑓: 0.10 ( 0 hom. )

Consequence

ATM
NM_000051.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.510

Publications

10 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP6
Variant 11-108250683-CT-C is Benign according to our data. Variant chr11-108250683-CT-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 183771.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.1236-3delT
splice_region intron
N/ANP_000042.3
ATM
NM_001351834.2
c.1236-3delT
splice_region intron
N/ANP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.1236-17delT
intron
N/AENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.1236-17delT
intron
N/AENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.1236-17delT
intron
N/AENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.00229
AC:
326
AN:
142158
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00213
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00168
Gnomad ASJ
AF:
0.000295
Gnomad EAS
AF:
0.00102
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00869
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00212
Gnomad OTH
AF:
0.00309
GnomAD2 exomes
AF:
0.136
AC:
22262
AN:
163404
AF XY:
0.135
show subpopulations
Gnomad AFR exome
AF:
0.169
Gnomad AMR exome
AF:
0.129
Gnomad ASJ exome
AF:
0.136
Gnomad EAS exome
AF:
0.180
Gnomad FIN exome
AF:
0.106
Gnomad NFE exome
AF:
0.131
Gnomad OTH exome
AF:
0.133
GnomAD4 exome
AF:
0.105
AC:
132458
AN:
1265300
Hom.:
0
Cov.:
0
AF XY:
0.104
AC XY:
65752
AN XY:
630112
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.152
AC:
4262
AN:
28122
American (AMR)
AF:
0.111
AC:
4042
AN:
36558
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
2367
AN:
22834
East Asian (EAS)
AF:
0.150
AC:
5226
AN:
34934
South Asian (SAS)
AF:
0.0947
AC:
7027
AN:
74178
European-Finnish (FIN)
AF:
0.102
AC:
3710
AN:
36290
Middle Eastern (MID)
AF:
0.0619
AC:
275
AN:
4446
European-Non Finnish (NFE)
AF:
0.102
AC:
99716
AN:
975262
Other (OTH)
AF:
0.111
AC:
5833
AN:
52676
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.276
Heterozygous variant carriers
0
11789
23579
35368
47158
58947
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
3614
7228
10842
14456
18070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00233
AC:
331
AN:
142178
Hom.:
0
Cov.:
0
AF XY:
0.00270
AC XY:
185
AN XY:
68516
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00225
AC:
87
AN:
38604
American (AMR)
AF:
0.00168
AC:
24
AN:
14264
Ashkenazi Jewish (ASJ)
AF:
0.000295
AC:
1
AN:
3392
East Asian (EAS)
AF:
0.00102
AC:
5
AN:
4888
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4506
European-Finnish (FIN)
AF:
0.00869
AC:
69
AN:
7944
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.00212
AC:
139
AN:
65468
Other (OTH)
AF:
0.00308
AC:
6
AN:
1948
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.368
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0832
Hom.:
575

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Ataxia-telangiectasia syndrome (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34325032; hg19: chr11-108121410; COSMIC: COSV53726499; COSMIC: COSV53726499; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.